This article provides a brief overview of various approaches that may be utilized for the analysis of human semen test results. Reference intervals are the most widely used tool for the interpretation of clinical laboratory results. Reference interval development has classically relied on concepts elaborated by the International Federation of Clinical Chemistry Expert Panel on Reference Values during the 1980s. These guidelines involve obtaining and classifying samples from a healthy population of at least 120 individuals and then identifying the outermost 5% of observations to use in defining limits for two-sided or one-sided reference intervals. More recently, decision limits based on epidemiological outcome analysis have also been introduced to aid in test interpretation. The reference population must be carefully defined on the basis of the intended clinical use of the underlying test. To determine appropriate reference intervals for use in male ferti lity assessment, a reference population of men with documented time to pregnancy of < 12 months would be most suitable. However, for epidemiological assessment of semen testing results, a reference population made up of unselected healthy men would be preferred. Although reference and decision limits derived for individual semen analysis test results will undoubtedly be the interpretational tools of choice in the near future, in the long term, multivariate methods for the interpretation of semen analysis alone or in combination with information from the female partner seem to represent better means for assessing the likelihood of achieving a successful pregnancy in a subfertile couple.
Introduction
This issue highlights the publication of the fifth edition of the World Health Organization (WHO) Laboratory Manual for the Examination and Processing of Human Semen [1] . Results will soon become available for an in-depth study of over 4 500 individuals undertaken by the Editorial Committee to establish reference values for use in human semen analysis [2] . These two documents contain the latest and the most comprehensive available information on techniques for assessing the characteristics of human semen and the likelihood of male fertility. Although the data gathered from human semen analysis comprise only a portion of the information used for assessing the likelihood of achieving viable pregnancy, careful interpretation of these results can help guide the selection of further examinations. The availability of extensive information regarding the setting of reference values for human semen tests will allow these tests to be better evaluated using established metrics for traditional clinical laboratory tests. The intent of this article is to examine the utility of reference values compared with possible alternative approaches for the evaluation of semen testing results, including decision limits and probability-based methods such as likelihood ratios.
Measurements are frequently interpreted by comparison with earlier measurements taken from the population at large. In clinical medicine, special attention is given to assem-84 npg bling sets of measurements in carefully defined groups of individuals that can provide a frame of reference for the clinical interpretation of subsequent laboratory test measures. These sets of 'reference' values or their predecessors, 'normal' values, have been used by physicians for generations to assist them in interpreting biochemical or physiological measurements in patients [3, 4] . Advanced theory on statistical approaches for the determination of reference values is available in the books by Harris and Boyd [5] and Horn and Pesce [6] . In addition, the Clinical Laboratory Standards Institute and the International Federation of Clinical Chemistry (IFCC) have issued detailed sets of guidelines regarding the determination of reference limits [7] [8] [9] [10] [11] [12] [13] . Therefore, only a brief overview of these concepts is provided here.
Decision limits are another tool that may aid in the interpretation of test results in specific clinical circumstances. In recent years, the distinction between reference limits and decision limits has become blurred by the introduction of limits that are based on epidemiological evidence regarding likely clinical outcomes for patients who have laboratory test results above or below the 'reference' limits. An example of such blurring is the current set of upper reference limits for cholesterol recommended by an expert panel for the National Cholesterol Education Program (NCEP) [14] , which is further discussed below. To clarify the distinction between classical reference limits and decision limits, we must delve into the definition of normality, how reference intervals are defined, and factors that can influence reference intervals.
What is normal?
Clinical laboratories have for many years reported results relative to 'normal' values. However, as pointed out by the philosopher Edmund Murphy [15] , the word 'normal' can be interpreted from many frames of reference. Using some of Murphy's definitions, a 'normal' sperm concentration might be: (1) the most representative sperm concentration as defined by the mean; (2) the most commonly encountered sperm concentrations as defined by an interval (i.e., the usual laboratory reference interval); (3) sperm concentrations associated with fertility; (4) a committee's consensus of 'approved' sperm concentrations; or (5) the ideal sperm concentration. Physicians are usually interested in 'normality' in terms of definitions (2) or (3). Typically, reference values or reference intervals are established for each laboratory test to delineate the range of values that would usually be encountered in a 'healthy' population.
Normality is relative. The 'normal' sperm concentration, for example, is influenced by many non-diseaserelated factors including age, endocrine status, physical activity, duration of abstinence, volume of ejaculate, and history of fertility. Cooper et al. [2] found that men in a population group with time to pregnancy of ≤ 12 months have demonstrably higher sperm concentrations than men in an unscreened population or men who have gone through screening examinations. Thus, refe ren ce values must be defined in terms of a specific referen ce population. In this case, if the desired comparison group consists of men with demonstrated fertility and time to pregnancy of ≤ 12 months, reference values should be defined for that specific population group and may differ from those defined for the population at large. Many have therefore replaced the label 'normal' interval with 'referen ce' interval, as these values merely provide a frame of reference for interpreting other results.
Definition of reference interval
The reference interval for many laboratory tests is defined by threshold values between which the test results of a specified percentage (usually 95%) of apparently healthy individuals would fall. The threshold or limiting values for the reference interval are usually the 0.025 and 0.975 fractiles of the test result distribution in the reference population ( Figure 1 ). This definition results in exclusion of the 2.5% of individuals with the lowest results and the 2.5% of individuals with the highest results from the reference interval. In case the clinical interest is only in 'low' results and high test results are not indicative of pathology (or, conversely, if only high test results are of interest), one-sided reference intervals are defined that exclude Figure 1 . The 95% reference intervals are derived by identifying the most outlying 5% of observed values in a reference population. Most often, these outlying observations are split evenly between the ends of the test result distribution in the reference population, 2.5% at each end of the distribution, resulting in a two-sided reference interval (A). For some tests (e.g., sperm concentration), only low values are of clinical concern, and therefore the 5% of outlying observations for the reference interval are identified and excluded only from the low end of the distribution, resulting in a one-sided reference interval (B). npg only the 5% of the population in the 'abnormal' tail of the distribution. In interpreting sperm concentration, for instance, only low concentrations are likely to be of clinical concern, and the use of the 0.05 fractile of the reference population as a one-sided lower reference limit makes the most sense.
Although this statistical definition of the reference interval has been applied to the majority of laboratory tests, reference intervals have more recently been defined on the basis of analysis of clinical outcomes. The reference limits for cholesterol defined by the NCEP [14] provide an example of this approach. Whereas the 97.5 percentile for cholesterol concentration in the general population lies between 280 and 300 mg dL −1 (7.25-7 .77 mmol L ), corresponding to approximately the 75th percentile. These values were chosen by the NCEP expert panel because they were associated with moderate and high risks for the development of cardiovascular disease in epidemiological outcome studies. For male fertility assessment, it seems reasonable to suggest that defining reference limits for human semen tests based on achieved rates of pregnancy in the reference population may ultimately be the preferred approach.
Another approach for defining reference intervals is emerging from the rapidly expanding knowledge base of the human genome. In this case, it is now known that the most commonly encountered values (reference values) for some analytes vary with the genotype (and/or phenotype) of the individual. Examples of this include haptoglobin (in which concentrations progressively decrease across the Hp 1-1, Hp 2-1, and Hp 2-2 phenotypes) [16] and HDL cholesterol (in which concentrations are lower in individuals carrying the Apo A1Milano mutation) [17] . Several genetic markers are known to have a role in male infertility [18] , and it is possible that as yet undefined genetic markers may influence observed reference intervals for tests of human semen or male fertility.
Factors in the determination of 'normal' or re ference intervals

Choice of population to study
Many factors must be considered in the determination of normal values or reference intervals. One extremely important factor is the choice of which population to study. Where the range of test values seen in healthy individuals is the primary concern, volunteers should be selected who reflect the overall healthy population. Possible approaches that can be used include studying a 'random' sample from a 'normal' population such as volunteer blood donors, door-to-door contacts, medical students, or medical technologists. Regardless of the reference population selected for study, there is always the potential that the specific group of individuals selected may not be representative of that population. As the same factors that lead individuals to volunteer for such a study (e.g., participants may volunteer owing to an underlying concern about their health, and study organizers have offered the inducement of free laboratory test results or a free medical evaluation) may also have an effect on their test results, the resulting population values may be biased.
If a particular population characteristic guides the definition of the reference population (e.g., demonstrably fertile males with time to pregnancy ≤ 12 months), then the reference population should reflect a random sampling of such individuals. On the other hand, if fertility is not the underlying concern, but rather the epidemiological relationship of an individual's semen analysis results to the population at large, then the most appropriate reference population will be made up of randomly selected healthy men from the general population. The fact that Cooper et al. [2] have shown statistically significant differences in semen analysis results between the fertile male population and the healthy male population at large strengthens the argument that where male fertility is the clinically important criterion, only reference values derived from a population of known fertile males should be used. However, the need to collect appropriate documentation of fertility and time to pregnancy for each reference interval makes studying this population a more difficult and expensive proposition than studying volunteers from the population at large. In addition, because of the factors pointed out above, it may be very difficult to recruit a set of volunteers who truly represent a random, unbiased sampling of the population of interest.
It should be pointed out that laboratory test results drawn from healthy populations in different geographical regions exhibit significant variation [19] . Ichihara et al. [20] conducted a follow-up study to explore possible causes of the between-city differences. Their study not only confirmed the presence of large between-city differences in several analytes, but also indicated a biological basis for this variation. In both studies, investigators removed the between-laboratory component of variability by analyzing deep-frozen specimens collected from six Asian cities in a single central laboratory. Although such differences may seem surprising, the fact that they were confirmed in two independent studies is compelling and suggests caution regarding the development of 'universal' reference intervals for worldwide application. Thus, although adherence to the fifth edition of the WHO manual for semen analysis [1] will serve to reduce variability between laboratories, the likelihood of regional differences in semen analysis results npg that have an underlying biological basis cannot be ignored in future epidemiological investigations that involve semen analysis.
Some researchers have attempted to derive a 'normal' population from easily accessed hospitalized patients by applying selection criteria (e.
Pre-analytical variables
In addition, variables of the study population itself that can affect test results must be carefully assessed and controlled (pre-analytical variables). For various laboratory tests, these variables can include age, diet, sex, circadian rhythm, race, posture, medications, physical activity, socioeconomic status, medical history, and fasting status. For semen analysis, in particular, variables likely to affect results include the age and endocrine status of the reference individual, as well as the period of abstinence before obtaining the semen sample.
Analytical variation
Clearly, differences in how the test procedure is performed or differences in interpretive criteria can have a major impact on the test results of reference intervals. These factors call for the highest degrees of test standardization and quality assessment. For the analysis of human semen, the fifth edition of the WHO Manual for the Exami nation and Processing of Human Semen [1] serves as an excellent resource to promote the standardization of test procedures and gives recommendations regarding ongoing quality control.
Calculation of the reference interval
Once a series of results have been generated for the selected reference population, the reference intervals can be calculated. Two methods have commonly been used for calculation of the reference interval from study data: With the parametric approach, the central 95% boundaries are specified by the mean ± 2SD, if the data follow a Gaussian (normal) distribution or can be transformed to a normal distribution by one of several two-step transformation methods [21] and with the non-parametric approach, the central 95% boundaries are determined by trimming off the lowest and highest 2.5% of observations. The latter method is used for skewed and other non-normal data distributions. The IFCC committee has developed a computer program called REFVAL that implements both parametric and non-parametric methods, including bootstrapping methods for generating confidence intervals around the reference interval limits [22] . Horn et al. [23] have described a robust method that provides a nonparametric approach for calculation of reference interval limits that allows use of the smaller reference populations and is more resistant to the effects of outlier results than either the parametric or non-parametric methods described above. The Clinical and Laboratory Standards Institute approved guidelines for determination of reference intervals provide more detailed guidance regarding the application of various calculation methods [7] .
As mentioned earlier, outcomes analysis is now being used for the determination of reference values for certain laboratory analytes. In the case of cholesterol, the incidence of cardiovascular disease in cohorts of patients stratified across cholesterol concentrations was utilized by the NCEP in defining risk thresholds for cholesterol. With the data gathered by Cooper et al. [2] , it may be possible to use a similar approach for setting reference limits based on the relative fertility of individuals whose semen test was at or below given threshold values.
Reference intervals and test interpretation
Reference intervals have several advantages in routine clinical applications, including their simplicity, ease of storage and retrieval from laboratory computer systems and pocket notebooks, and their high degree of acceptance by the medical community through long use. However, reference intervals are not ideal for interpreting laboratory results in many circumstances.
Reference intervals have several disadvantages. If the reference interval has been derived from a population dissimilar to the individual tested, it may give a misleading impression of the status of the individual patient. In addition, reference intervals are relatively inflexible instruments and do not take into account any special history or other characteristics of the patient. Thus, if the patient is a strict vegetarian or a diabetic, for example, and either of these conditions affects the results of the laboratory test under consideration, the reference interval for that test as derived from the general healthy population (most of whom are not vegetarians or diabetics) will not provide the correct basis for comparison. Furthermore, the statistical definition of the reference interval may not allow certain clinical uses. As a specific example, because reference intervals are statistically derived with respect to only the healthy population, they cannot be used to rule in or rule out specific conditions such as male infertility.
Owing to the statistical manner in which the 95% reference interval is defined, 5% of normal subjects will be npg 'abnormal' (i.e., have values for a single test that fall outside of the reference interval). This definition often leads to the misconception that 95% of the diseased individuals will have test results that lie outside the reference interval. This is rarely, if ever, true. Instead, the number of diseased individuals who fall outside the reference interval must be determined by study of the distribution of results in a defined population with the target condition. If we refer to hypothetical distributions of sperm concentration test results in fertile and infertile men (Figure 2) , we note that the test results for the fertile and infertile populations show quite a bit of overlap. This occurrence is the rule, not the exception. Many individuals in the infertile population can have results that are within the fertile population reference interval. Thus, just as finding that an individual's result is outside the reference interval does not imply that the man is infertile (because 5% of fertile individuals, by definition, have results in the 'abnormal' range); finding that an individual's result lies within the reference interval does not imply with certainty that this individual will be fertile.
Part of the reason that overlap has been observed in the distributions of test results in fertile and infertile individuals is that determination of fertility is dependent on many variables beyond the tests performed in the examination of semen. Examination of any single test result from a semen examination will not necessarily provide a definitive projection of infertility in a given patient. A potential solution to this problem is to develop a multidimensional reference region, a topic that is too complex to cover here [24] . However, there are other multivariate approaches that are superior to multidimensional reference regions, and these are covered below.
When test results for both fertile and infertile individuals are available, various approaches can be utilized to set decision limits for laboratory tests by examining the test sensitivity (rate of positive test results in infertile individuals) and test specificity (rate of negative test results in fertile individuals) at various test threshold settings. Such thresholds are best set by the use of receiver operating characteristic analysis [25] . Examples of studies that have used this approach for setting decision limits of tests in semen analysis include those by Gunalp et al. [26] and NasrEsfahani et al. [27] .
A final disadvantage of the reference interval is that information in a laboratory result is lost when it is converted to 'low', 'normal', or 'high'. Thus, for example, a patient with a sperm concentration of 10 million mL −1 will be regarded as having a value below the reference limit, as would a patient whose concentration is < 100 000 mL −1 . However, the latter patient is likely to have a completely different clinical evaluation for infertility compared with the former patient. A tool for aiding the interpretation of a laboratory test that retains quantitative information would be a useful addition and we will turn to this topic next.
Alternatives to the reference interval
From the above list of disadvantages, we can see that reference intervals are imperfect data interpretational aids. How might we reduce the rigidity and arbitrariness of '95% reference intervals'? One possible solution would be to use a universal scale for reporting results.
Universal scales
Several universal scales have been suggested. First, results could be reported in terms of the number of stan- Figure 2 . Distributions of test results for sperm concentration are plotted for the hypothetical population subgroups of fertile and infertile men. As these are hypothetical distributions, no specific sperm concentrations are indicated on this graph. Infertile men as a group are displayed as having lower average sperm concentrations than fertile men, and more infertile than fertile men have sperm concentrations below the lower reference limit (shaded area). The relative heights of the distribution curve for each group of men are displayed for several vertical line segments, each of which represents a different sperm concentration. The ratios of distribution heights for the infertile men/fertile men represent the likelihood ratios for infertility at each sperm concentration. Thus, for the line segment at the farthest left, corresponding to a low sperm concentration, the ratio of line heights is 6/1, yielding a likelihood ratio for infertility of 6. Conversely, at the line segment to the farthest right, corresponding to a higher sperm concentration, the ratio of line heights is 4/21, which gives a likelihood ratio for infertility approximately equal to 0.2. npg dard deviations away from the population mean. However, for consistency of interpretation, this approach requires that data follow a normal distribution and it does not directly indicate the probability of a fertile individual having a given result.
Another approach would be to report results in percentiles. Although this approach does not require data to follow a normal distribution, it does require that all data from the reference group be available or that a suitable equation be available for transforming a result into a percentile. Computer transformation of results directly to percentiles can be accomplished in two ways: (1) transforming results to a Gaussian scale [20] and then estimating the percentiles or (2) tabular storage of all results from the reference population and matching the patient result with the appropriate reference percentile.
Likelihood ratios
The goal of a study to evaluate the diagnostic accuracy of a given laboratory test is to establish whether a relationship exists between the test result and a clinically defined end point (e.g., presence or absence of a disease or likelihood of fertility). The strength of any relationship must be evaluated to establish the utility of the marker in predicting disease or outcome in the individual patient. It is assumed that the clinical outcome category (disease vs. non-disease, fertile or infertile) can be accurately assessed by some independent criterion (a so-called reference standard or 'gold standard'). In the case of male infertility, definition of such a gold standard may be difficult, as infertility is a multifactorial trait that requires consideration of factors pertaining to both the man and the woman in a given couple.
The likelihood ratio of a test value (x) for analyte X is written L(X = x), or simply L(x), and is defined as [28] :
Likelihood ratios state how many times more likely particular test results are in patients with the condition than in those without it. For example, if the likelihood ratio is 10 for a test result, the probability of a person having that result in the population with the condition is 10 times the probability of a person having the same result in the population without the condition. Likewise, if the likelihood ratio is 0.01 for a test result, the probability of having that result in the study population with the condition is 100th that of having the same result without the condition. Thus, the farther a likelihood ratio deviates from a value of one (equal probabilities in the affected and unaffected populations), the more informative the test result corresponding to that likelihood ratio becomes. Examples of the calculation of positive likelihood ratio values are given in Figure 2 using the hypothetical distributions shown.
Likelihood ratios < 0.1 or > 10 have been described as providing convincing diagnostic evidence, whereas those < 0.2 or > 5 give strong diagnostic evidence [29] . How ever, these guideline figures will not apply when pretest suspicions of the presence of the condition are very high or very low. In these situations, likelihood ratios with values tending towards the low or the high extremes will be needed to rule out or rule in diagnoses, respectively.
With use of Bayes' theorem, likelihood ratios can be directly applied to derive probabilistic statements regarding the likelihood of a condition in an individual [28] . When applying this approach, likelihood ratios allow computation of post-test probabilities by the following formula:
Post-test odds = pre-test odds × likelihood ratio Suppose that the rate of infertility in outpatients is 5%, and the likelihood ratio for a specific sperm concentration from an individual is 6 (see Figure 2) , then
Pre-test odds = prevalence/(1 -prevalence) = 0.05/0.95 = 0.053 Applying Bayes' theorem to the pooled negative likelihood ratio:
Post-test odds = pre-test odds × likelihood ratio = 0.053 × 6 = 0.32 Converting post-test odds to post-test probability: Post-test probability of infertility = post-test odds/(1 + post-test odds) = 0.32/(1 + 0.32) = 0.24 or 24 percent.
Such an approach would allow more complete use of the quantitative information available from semen analysis and would give an associated probability of having an outcome of infertility.
Difficulties commonly arise when trying to apply Bayes' theorem to update pre-test probabilities using the results of several tests, due to the non-independence of the test results. Albert [28] has described an approach in which the likelihood ratio for a combination of test results can be estimated using logistic regression. Although the contributions of individual tests to the final likelihood ratios cannot be discerned, the approach allows overall likelihood ratios for all possible combinations of test results to be deduced. The Albert model also allows inclusion of continuous test results dependent on assumptions being made about linearity. The derivation of the Albert model uses the data from a diagnostic accuracy study. Using as a 'training set' the test values from each person in a group of patients with and without the condition, logistic regression analysis can be applied to derive maximum likelihood estimates for the likelihood ratios. An example of this multivariate approach as applied to gestational monitoring is given in Boyd [30] . It is commonly recommended that the performance of models produced using these approaches be validated in new data sets. 
More global multivariate models
For a more global prediction of fertility at the level of the couple, employing both information from the female partner and data from semen analysis, Hunault et al. [31] have developed two models of time to pregnancy based on Cox regression analysis of maternal factors, test results of semen analysis, referral status, and for one of the models, the results of post-coital testing. These models have been evaluated in an independent data set and seem to be useful in the evaluation of subfertile couples [32] . Such studies show the potential value of multivariate data analyses that incorporate the results of semen analysis with additional data.
Summary
This article provides a brief review of the various approaches that may be utilized for the analysis of human semen test results. Improvements in and standardization of the techniques for collection and analysis of human semen, as provided in the latest edition of the WHO manual should help reduce between-laboratory variability of semen analysis results [1] . The development of reference values for these results as provided by data from the large, multicentre reference interval study carried out by Cooper et al. [2] will help in efforts to standardize the interpretation of semen analysis. Although reference limits and decision limits derived for individual test results of semen analysis will undoubtedly be the tools of choice in the short term, in the long term, multivariate likelihood ratio methods for the interpretation of semen analysis alone or more complex predictive models that combine information from semen analysis with data derived from the female partner seem to represent better means for assessing the likelihood of achieving a successful pregnancy in a subfertile couple.
